In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies
Blood Cancer J
.
2024 Mar 15;14(1):46.
doi: 10.1038/s41408-024-01036-4.
Authors
Zhiqiang Song
#
1
,
Ping Liu
#
1
,
Dongliang Zhang
#
1
,
Tao Wang
1
,
Wenqin Yue
1
,
Yuke Geng
1
,
Na Liu
2
,
Yang Wang
3
,
Jianmin Yang
4
Affiliations
1
Department of Hematology, Institute of Hematology, Changhai Hospital, Naval Medical University, 200433, Shanghai, China.
2
Department of Hematology, Institute of Hematology, Changhai Hospital, Naval Medical University, 200433, Shanghai, China. nanabest520@163.com.
3
Department of Hematology, Institute of Hematology, Changhai Hospital, Naval Medical University, 200433, Shanghai, China. yang060124@126.com.
4
Department of Hematology, Institute of Hematology, Changhai Hospital, Naval Medical University, 200433, Shanghai, China. chyangjianmin@163.com.
#
Contributed equally.
PMID:
38485926
PMCID:
PMC10940594
DOI:
10.1038/s41408-024-01036-4
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Bispecific*
Antigens, CD19
CD3 Complex
Humans
Liver / pathology
Neoplasms* / pathology
Substances
CD3 Complex
Antibodies, Bispecific
Antigens, CD19
Grants and funding
82270202/National Natural Science Foundation of China (National Science Foundation of China)
82100162/National Natural Science Foundation of China (National Science Foundation of China)
82300257/National Natural Science Foundation of China (National Science Foundation of China)